Comments Subscribe to Personal Liberty News Feed Subscribe to Personal Liberty
 

Experimental Contact Lens Releases Glaucoma Medicine

BOSTON (UPI) — An experimental specially designed contact lens releases a glaucoma medicine at a steady rate for up to a month and corrects vision, U.S. researchers say.

Joseph Ciolino, an ophthalmologist, who, along with his mentor Daniel Kohane, developed the new contact lens at Harvard Medical School, said people using traditional eye drops for glaucoma “aren’t getting any symptomatic relief, and they’re not seeing better, so there’s not a lot of motivation to be compliant with the medication.”

Glaucoma is a group of conditions that can result in irreversible blindness. This vision loss can be reduced if glaucoma is found and treated early, most commonly with eye drops to lower pressure within the eye.

But using eye drops regularly can be a challenge and while the drops can minimize further vision loss, they don’t repair vision that’s already lost, Ciolino said.

Like a miniature doughnut stuffed inside a tiny pita pocket, a common glaucoma medicine is sandwiched inside this specially designed contact lens, Ciolino said.

In laboratory experiments, the lens, which can also correct vision, releases the eyesight-saving medication at a steady rate for up to a month. Its construction offers numerous potential clinical advantages over the standard glaucoma treatment and might have additional applications, such as delivering anti-inflammatory drugs or antibiotics to the eye.

The new lens is different from other prototypes because it’s the many-layered construction that places a ring of drug-releasing film in standard, government-approved contact lens materials. Other designs have most often used a pre-made lens dipped in a drug solution, which then leached out into the eye rapidly and inconsistently, Kohane explained.

UPI - United Press International, Inc.

Since 1907, United Press International (UPI) has been a leading provider of critical information to media outlets, businesses, governments and researchers worldwide.

Facebook Conversations

Join the Discussion:
View Comments to “Experimental Contact Lens Releases Glaucoma Medicine”

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.

Is there news related to personal liberty happening in your area? Contact us at newstips@personalliberty.com

Bottom
close[X]

Sign Up For Personal Liberty Digest™!

PL Badge

Welcome to PersonalLiberty.com,
America's #1 Source for Libertarian News!

To join our group of freedom-loving individuals and to get alerts as well as late-breaking conservative news from Personal Liberty Digest™...

Privacy PolicyYou can opt out at any time. We protect your information like a mother hen. We will not sell or rent your email address to anyone for any reason.